Yale Study Finds 0 Link Between Adult Thymectomy and 5-Year Mortality
Updated
Updated · ScienceAlert · Jun 16
Yale Study Finds 0 Link Between Adult Thymectomy and 5-Year Mortality
1 articles · Updated · ScienceAlert · Jun 16
Summary
A 2025 Yale School of Medicine analysis found adult thymectomy was not associated with higher five-year overall mortality or cancer death in patients with small or localized thymomas.
The team reviewed records from the National Cancer Database and SEER spanning 2004 to 2022 and said its data showed no measurable harm from removing the thymus in those adults.
That result directly challenges a 2023 Boston-led observational study of 1,146 thymectomy patients versus more than 6,000 controls, which reported roughly doubled risks of death and cancer within five years.
The earlier study also found less diverse T-cell receptors after surgery, suggesting a possible immune mechanism, but Yale's conflicting findings leave the adult thymus's long-term role unresolved and in need of further study.
With top universities offering conflicting data, how can patients decide if removing a vital immune organ is safe?
Once considered useless, is the thymus gland actually the key to predicting your risk of cancer and early death?
The Adult Thymus Controversy: New Data on Thymectomy, Mortality, and Immune Health Risks
Overview
For many years, the adult thymus was thought to be a vestigial organ with little role in adult health. However, recent research has challenged this view. A pivotal 2023 study from MGH/Harvard found that removing the adult thymus (thymectomy) is linked to a reduced lifespan and higher all-cause mortality compared to controls. These findings suggest the adult thymus continues to play an important role in immune health. This new evidence has sparked debate in the medical community, highlighting the need to reconsider the significance of the thymus in adults and to carefully weigh the risks of thymectomy.